[go: up one dir, main page]

DK582689A - Fremgangsmaade til paavisning af aids-infektion og proevesaet til anvendelse ved fremgangsmaaden - Google Patents

Fremgangsmaade til paavisning af aids-infektion og proevesaet til anvendelse ved fremgangsmaaden

Info

Publication number
DK582689A
DK582689A DK582689A DK582689A DK582689A DK 582689 A DK582689 A DK 582689A DK 582689 A DK582689 A DK 582689A DK 582689 A DK582689 A DK 582689A DK 582689 A DK582689 A DK 582689A
Authority
DK
Denmark
Prior art keywords
procedure
determining
aids infection
aids virus
aids
Prior art date
Application number
DK582689A
Other languages
Danish (da)
English (en)
Other versions
DK582689D0 (da
Inventor
Franklin Volvovitz
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Publication of DK582689D0 publication Critical patent/DK582689D0/da
Publication of DK582689A publication Critical patent/DK582689A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK582689A 1988-11-21 1989-11-20 Fremgangsmaade til paavisning af aids-infektion og proevesaet til anvendelse ved fremgangsmaaden DK582689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27419788A 1988-11-21 1988-11-21

Publications (2)

Publication Number Publication Date
DK582689D0 DK582689D0 (da) 1989-11-20
DK582689A true DK582689A (da) 1990-05-22

Family

ID=23047193

Family Applications (1)

Application Number Title Priority Date Filing Date
DK582689A DK582689A (da) 1988-11-21 1989-11-20 Fremgangsmaade til paavisning af aids-infektion og proevesaet til anvendelse ved fremgangsmaaden

Country Status (14)

Country Link
EP (1) EP0370573B1 (de)
JP (1) JPH02262527A (de)
KR (1) KR900007384A (de)
CN (1) CN1043081A (de)
AT (1) ATE126706T1 (de)
AU (1) AU630129B2 (de)
BR (1) BR8905851A (de)
CA (1) CA2003300A1 (de)
DE (1) DE68923932T2 (de)
DK (1) DK582689A (de)
IL (1) IL92374A (de)
LV (1) LV10203B (de)
NO (1) NO894614L (de)
ZA (1) ZA898833B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6224882B1 (en) 1997-11-07 2001-05-01 Protein Science Corp. Insect cells or fractions as adjuvant for antigens
EP1545575A4 (de) 2002-09-19 2006-04-05 Us Gov Health & Human Serv P. ariasi polypeptide, p. perniciosus polypeptide und anwendungsverfahren
US7485306B2 (en) 2002-10-29 2009-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Lutzomyia longipalpis polypeptides and methods of use
EP2390352A1 (de) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systeme und Methoden zur Erhöhung der Milchproduktion bei Tieren
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
MXPA06009452A (es) 2004-02-19 2007-03-15 Univ Alberta Polimorfismos del promotor de leptin y sus usos.
ATE461710T1 (de) 2005-04-25 2010-04-15 Merial Ltd Nipah-virus-impfstoffe
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
WO2007056614A1 (en) 2005-11-14 2007-05-18 Merial Limited Gene therapy for renal failure
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
EP2899203B1 (de) 2008-05-08 2019-07-10 Boehringer Ingelheim Animal Health USA Inc. Leishmania impfstoff unter verwendung von sandmücken speichelimmunogen
WO2010115133A2 (en) 2009-04-03 2010-10-07 Merial Limited Newcastle disease virus vectored avian vaccines
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CA2809127C (en) 2010-08-31 2019-04-02 Merial Limited Newcastle disease virus vectored herpesvirus vaccines
AR083533A1 (es) 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
AU2012240240A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
WO2012138789A2 (en) 2011-04-04 2012-10-11 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment
US9216213B2 (en) 2011-04-20 2015-12-22 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
CA2834288A1 (en) 2011-04-25 2012-11-01 Advanced Bioscience Laboratories, Inc. Truncated hiv envelope proteins (env), methods and compositions related thereto
WO2012166493A1 (en) 2011-06-01 2012-12-06 Merial Limited Needle-free administration of prrsv vaccines
PT2734230T (pt) 2011-07-20 2019-02-27 Roussy Inst Gustave Vacina recombinante contra o vírus da leucemia felina contendo um gene de envelope do vírus da leucemia felina otimizado
HUE035774T2 (en) 2011-08-12 2018-05-28 Merial Inc Biological substances, in particular vaccines, preserved by vacuum
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal
WO2013033092A2 (en) 2011-09-03 2013-03-07 Boehringer Ingelheim Vetmedica Gmbh Streptococcus suis pilus antigens
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
AU2013235423B2 (en) 2012-03-20 2017-03-30 Boehringer Ingelheim Animal Health USA Inc. Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
WO2014127825A1 (en) 2013-02-21 2014-08-28 Boehringer Ingelheim Vetmedica Gmbh H5 proteins of h5n1 influenza virus for use as a medicament
US9556419B2 (en) 2013-03-12 2017-01-31 Merial Inc. Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof
CA2943816A1 (en) 2014-04-03 2015-10-08 Boehringer Ingelheim Vetmedica, Inc. Porcine epidemic diarrhea virus vaccine
MX2017005687A (es) 2014-11-03 2017-08-21 Merial Inc Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
US9981033B2 (en) 2015-06-23 2018-05-29 Merial Inc. PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
UA124140C2 (uk) 2015-08-31 2021-07-28 Бьорінгер Інгельхайм Ветмедіка Гмбх Пестивірусна вакцина проти вродженого тремору поросят
CA2996613A1 (en) 2015-09-16 2017-03-23 Boehringer Ingelheim Vetmedica, Inc. Salmonella choleraesuis-salmonella typhimurium vaccines
EA201990718A1 (ru) 2016-09-20 2019-10-31 Векторы аденовируса собачьих
BR112019005516A2 (pt) 2016-09-20 2019-06-18 Boehringer Ingelheim Vetmedica Gmbh novo sítio de inserção do ehv orf70
AU2017329672B2 (en) 2016-09-20 2023-07-27 Boehringer Ingelheim Vetmedica Gmbh New promoters
CN110072546B (zh) 2016-09-20 2023-10-31 勃林格殷格翰动物保健有限公司 新的猪流感疫苗
BR112019009133A2 (pt) 2016-11-03 2019-07-16 Boehringer Ingelheim Vetmedica Gmbh vacina contra o parvovírus suíno
PL3534939T3 (pl) 2016-11-03 2023-06-12 Boehringer Ingelheim Vetmedica Gmbh Szczepionka przeciw parwowirusowi świń i wirusowi zespołu rozrodczo-oddechowego świń oraz sposoby ich wytwarzania
MX2019008974A (es) 2017-01-30 2019-10-09 Boehringer Ingelheim Animal Health Usa Inc Vacunas contra el coronavirus porcino.
CA3068052A1 (en) 2017-07-12 2019-01-17 Boheringer Ingelheim Animal Health Usa Inc. Senecavirus a immunogenic compositions and methods thereof
JP7038804B2 (ja) 2017-09-23 2022-03-18 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー パラミクソウイルス科の発現系
WO2019092027A1 (en) 2017-11-09 2019-05-16 Boehringer Ingelheim Vetmedica Gmbh Sapelovirus immunogenic compositions and uses thereof
AU2019223768A1 (en) 2018-02-23 2020-08-27 Boehringer Ingelheim Animal Health USA Inc. Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
US11596681B2 (en) 2018-03-19 2023-03-07 Boehringer Ingelheim Vetmedica Gmbh EHV insertion site UL43
UY38148A (es) 2018-03-19 2019-10-01 Boehringer Ingelheim Vetmedica Gmbh Composiciones inmunogénicas de ehv que contienen ul18 y/o ul8 inactivados
KR20200135505A (ko) 2018-03-26 2020-12-02 베링거 인겔하임 애니멀 헬스 유에스에이 인크. 면역원성 조성물의 제조방법
US10905758B2 (en) 2018-09-20 2021-02-02 Boehringer Ingelheim Vetmedica Gmbh Intranasal vector vaccine against porcine epidemic diarrhea
JP7284822B2 (ja) 2018-09-20 2023-05-31 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 改変pedvスパイクタンパク質
US11858962B2 (en) 2020-02-06 2024-01-02 Boehringer Ingelheim Vetmedica Gmbh Polypeptides useful for detecting anti-rhabdovirus antibodies
CN116438195A (zh) 2020-10-05 2023-07-14 勃林格殷格翰动物保健有限公司 用于针对轮状病毒疫苗接种的融合蛋白质
CN116438202A (zh) 2020-10-05 2023-07-14 勃林格殷格翰动物保健美国有限公司 包含圆环病毒科衣壳蛋白的融合蛋白及其构成的嵌合病毒样颗粒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3029226A1 (de) * 1980-08-01 1982-03-18 Günter 8510 Fürth Fürther Diabetiker-set
GB8422513D0 (en) * 1984-09-06 1984-10-10 Wellcome Found Immunodiagnostic methods
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
IL84154A0 (en) * 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
EP0272858A3 (de) * 1986-12-15 1989-07-12 Repligen Corporation Rekombinante HIV-Hüllen-Proteine, hergestellt in Insektenzellen
DE3855869T2 (de) * 1987-02-20 1997-10-02 Genentech Inc Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
AU3063389A (en) * 1988-01-08 1989-08-01 Dpz Deutsches Primatenzentrum Gesellschaft M.B.H. Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions

Also Published As

Publication number Publication date
KR900007384A (ko) 1990-06-01
DE68923932D1 (de) 1995-09-28
EP0370573A3 (de) 1991-08-14
JPH02262527A (ja) 1990-10-25
IL92374A (en) 1994-02-27
ZA898833B (en) 1990-08-29
EP0370573B1 (de) 1995-08-23
ATE126706T1 (de) 1995-09-15
AU630129B2 (en) 1992-10-22
CA2003300A1 (en) 1990-05-21
EP0370573A2 (de) 1990-05-30
IL92374A0 (en) 1990-07-26
DE68923932T2 (de) 1996-01-11
NO894614L (no) 1990-05-22
LV10203A (lv) 1994-10-20
AU4533589A (en) 1990-05-24
CN1043081A (zh) 1990-06-20
BR8905851A (pt) 1990-06-12
LV10203B (en) 1995-04-20
DK582689D0 (da) 1989-11-20
NO894614D0 (no) 1989-11-20

Similar Documents

Publication Publication Date Title
DK582689A (da) Fremgangsmaade til paavisning af aids-infektion og proevesaet til anvendelse ved fremgangsmaaden
ATE229978T1 (de) Helicobacter proteine und impstoffe
DK0851927T3 (da) Forbindelser til immunterapi og diagnosticering af tuberkulose
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
NL930133I2 (nl) Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
DK0957935T3 (da) Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
DK272688A (da) Vaccine og fremgangsmaade til fresmtilling deraf
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DE68917108D1 (de) Methode des Aufbaus eines optoelektronischen Gehäuses und Vorrichtung.
FR2563434B1 (fr) Vaccin contre la rage et procede pour sa preparation
DK257389A (da) Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf
DK311485A (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
EP0571536A4 (de) Reagentien und methoden zur identifizierung von impfstoffen.
DK155886D0 (da) Vaccine og fremgangsmaade til fremstilling af denne
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
DK313687A (da) Fremgangsmaade til fremstilling af et antigen og vaccine indeholdende dette antigen
NO884167D0 (no) Matterte polymergjenstander og fremgangsmaate for deres fremstilling.
DK597585A (da) Leukaemi-associeret virusimmunogen, vaccine og analyse
MX9700215A (es) Proteinas y vacunas de helicobacter.
NO882843L (no) Humane pankreas-sekretoriske trypsin-inhibitorer fremstilt ved rekombinant-dna-metoder og fremgangsmaater til fremstilling av disse.
PL271748A1 (en) Method of obtaining inactivated vaccine against cattle dermatomycosis
DK123090A (da) Fremgangsmaade ved dyrkning, indhoestning og efterbehandling af hyben samt apparater til udoevelse af fremgangsmaaden

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment